Smart City City Foresight (13).png
SynBio x Climate Case Fund 

Connect and learn with impact investors to co-lead a venture round in SynBio x Climate

Smart City City Foresight (11).png

Connect and learn with impact investors to co-lead a venture round in SynBio x Climate

Synthetic Biology (SynBio) will change how we live, how diseases are cured, and how we combat climate change in the next decade. It is an emerging technology that makes it possible to systematically and predictably engineer biological systems, giving us unprecedented capability to solve complex and intractable problems in the world.


Recognizing the tremendous climate benefits and future growth of SynBio innovations, Vectors Angel is launching a $1M Case Fund to bring impact investors together to co-lead a Seed or Series A investment in a SynBio startup solving climate problems.

SynBio x Climate

With the potential to generate biological products that substitute almost 60% of the physical inputs to the global economy, from food, bio-based chemicals and materials, to consumer products, SynBio can help us:

Reduce greenhouse gas emission in agriculture, food production, and manufacturing. 

Move away from industrial processes that are petroleum-based with the use of renewable bio- based resources.

crude.png

Replace anthropogenic mass with biomass to reduce harmful human- made products and waste in our ecosystem. 

biomass.png
co2-cloud.png

This is the decade for SynBio 

As SynBio enters a new era of commercial success with biomanufacturing and DNA synthesis companies closing their IPOs and privately held SynBio unicorns such as 

  • Impossible Foods (valued at $5.2B) 

  • Pivot Bio (valued at $1.7B) 

  • Mammoth Biosciences (valued at $1B) 

disrupt what we eat, how farmers grow crops, and how we read and write the code of life, this decade will see SynBio unleashing a waterfall of new products and processes that define our world for generations to come.

Smart City City Foresight (12).png

SynBio Market Size

$30.7 B

CAGR
26.5%

$9.5 B

2021

2026

What is SynBio x Climate Case Fund?

The case fund is a special purpose vehicle (SPV) that expands the scope and scale of traditional angel investments by allowing the syndicate to raise a larger sum of capital and lead an investment round as opposed to participating with a small check size.
Conference
Done Deal

Why invest in SynBio x Climate Case Fund?

By participating in this fund as a limited partner, you will:
  • Participate in a round as lead investor and make impacts and returns
  • Develop understanding of the rapidly-growing SynBio x Climate industry through access to deals
  • Engage in the full venture investment cycle: from deal sourcing, due diligence, to investment committee
  • Network with startups, experts, angel investors, and VCs in this space
Moving People

Who are we looking for?

Vectors Angel is looking to collaborate with limited partners who: 

  • Are accredited investors 

  • Believe in and support founders 

  • Are passionate about climate and creating impact on the world and their communities 

  • Can bring additional guidance and industry expertise to our team Are actively engaged in Vectors' missions 

Smart City City Foresight (12).png

Company Stage & Return Expectation

The Case Fund will invest in a Seed / Series A startup at the intersection of climate and SynBio that has trusted technologies and low risk.

growth-graph.png
Seed Companies

Seed Companies will have developed working prototypes and are engaged in pilot projects that will accelerate the growth of their technologies. This stage carries greater risk at a lower valuation.

sprout (1).png
Series A Companies

Series A Companies will have already proven their product in the field and have achieved traction and revenue. We will be prioritizing go-to market strategies and long-term viability. The round size for Series A is substantially higher than Seed. 

bg.jpg
What is in it for startups? 

We understand the challenges of commercializing bio-based solutions.  Typically, the time from early stage research to full-scale manufacturing can span a decade or more. Furthermore, each stage of development has its own challenges. These delays in the process introduce uncertainty into bio-based ventures.  We want to build an ecosystem to accelerate the time to commercialization and reduce the uncertainty.  Here is how: 

enter (1).png

ACCESS

Connect with leading synbio companies and industry experts with the potential for developing go-to-market partnerships and advisor relationships 

handshake (1).png

PARTNERSHIP

At no cost to startups, the Challenge provides introductions to strategic partners, advisors, mentors and investors

network (1).png

COLLABORATION

The BioInnovation x Climate Challenge is building a community around bio-based ventures 

VALIDATION

Vectors Capital due diligence evaluates your concept

Microscope_edited.jpg
Purpose

Biology is not only about dissecting frogs or learning how organisms exist in their native environment. Today it is changing how we live, how diseases are cured and how we will combat climate change.

Synthetic biology is using modern tools to open up a whole new field of biology – where organisms are redesigned for useful purposes by engineering them to have novel functions. These new manufacturing engines make it possible for us to harness the power of nature to solve complex and previously intractable problems in the world.